Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-05-19 @ 1:23 PM
Study NCT ID:
NCT01493960
Status:
COMPLETED
Last Update Posted:
2023-01-10
First Post:
2011-12-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patients
Sponsor:
InDex Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CSUC-01/10
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None